Published in Am J Trop Med Hyg on June 26, 2001
Artemisinin-based combination therapies: a vital tool in efforts to eliminate malaria. Nat Rev Microbiol (2009) 3.84
Impact of malaria during pregnancy on low birth weight in sub-Saharan Africa. Clin Microbiol Rev (2004) 3.45
Protective efficacy of interventions for preventing malaria mortality in children in Plasmodium falciparum endemic areas. Int J Epidemiol (2010) 2.91
Insecticide-treated nets for the prevention of malaria in pregnancy: a systematic review of randomised controlled trials. PLoS Med (2007) 2.80
High-throughput pooling and real-time PCR-based strategy for malaria detection. J Clin Microbiol (2009) 2.52
New insights into acquisition, boosting, and longevity of immunity to malaria in pregnant women. J Infect Dis (2012) 2.52
Knowledge of malaria influences the use of insecticide treated nets but not intermittent presumptive treatment by pregnant women in Tanzania. Malar J (2004) 2.25
Antenatal receipt of sulfadoxine-pyrimethamine does not exacerbate pregnancy-associated malaria despite the expansion of drug-resistant Plasmodium falciparum: clinical outcomes from the QuEERPAM study. Clin Infect Dis (2012) 2.19
Diagnosis of Plasmodium falciparum malaria at delivery: comparison of blood film preparation methods and of blood films with histology. J Clin Microbiol (2003) 2.09
Use of antenatal care, maternity services, intermittent presumptive treatment and insecticide treated bed nets by pregnant women in Luwero district, Uganda. Malar J (2008) 2.05
Reduction in preterm delivery and neonatal mortality after the introduction of antenatal cotrimoxazole prophylaxis among HIV-infected women with low CD4 cell counts. J Infect Dis (2006) 2.05
Comparison of real-time PCR and microscopy for malaria parasite detection in Malawian pregnant women. Malar J (2010) 1.94
Delivering interventions to reduce the global burden of stillbirths: improving service supply and community demand. BMC Pregnancy Childbirth (2009) 1.90
Timing of intermittent preventive treatment for malaria during pregnancy and the implications of current policy on early uptake in north-east Tanzania. Malar J (2008) 1.85
Influence of the timing of malaria infection during pregnancy on birth weight and on maternal anemia in Benin. Am J Trop Med Hyg (2011) 1.80
Placental tumor necrosis factor alpha but not gamma interferon is associated with placental malaria and low birth weight in Malawian women. Infect Immun (2003) 1.68
Which family members use the best nets? An analysis of the condition of mosquito nets and their distribution within households in Tanzania. Malar J (2010) 1.67
The combined effect of determinants on coverage of intermittent preventive treatment of malaria during pregnancy in the Kilombero Valley, Tanzania. Malar J (2011) 1.66
Decline of placental malaria in southern Ghana after the implementation of intermittent preventive treatment in pregnancy. Malar J (2007) 1.66
Knowledge and utilization of intermittent preventive treatment for malaria among pregnant women attending antenatal clinics in primary health care centers in rural southwest, Nigeria: a cross-sectional study. BMC Pregnancy Childbirth (2009) 1.65
Infection-related stillbirths. Lancet (2010) 1.64
Access and barriers to measures targeted to prevent malaria in pregnancy in rural Kenya. Trop Med Int Health (2008) 1.60
Prospects, achievements, challenges and opportunities for scaling-up malaria chemoprevention in pregnancy in Tanzania: the perspective of national level officers. Malar J (2008) 1.59
Individual, facility and policy level influences on national coverage estimates for intermittent preventive treatment of malaria in pregnancy in Tanzania. Malar J (2008) 1.55
The safety of artemisinins during pregnancy: a pressing question. Malar J (2007) 1.54
Clinical malaria in African pregnant women. Malar J (2008) 1.54
Detection and clinical manifestation of placental malaria in southern Ghana. Malar J (2006) 1.52
Dihydroartemisinin-Piperaquine for the Prevention of Malaria in Pregnancy. N Engl J Med (2016) 1.51
Is the scale up of malaria intervention coverage also achieving equity? PLoS One (2009) 1.51
Dimerization of Plasmodium vivax DBP is induced upon receptor binding and drives recognition of DARC. Nat Struct Mol Biol (2011) 1.48
Maternal malaria and perinatal HIV transmission, western Kenya. Emerg Infect Dis (2004) 1.45
Impact of malaria at the end of pregnancy on infant mortality and morbidity. J Infect Dis (2011) 1.45
Effectiveness of intermittent preventive treatment with sulfadoxine-pyrimethamine during pregnancy on maternal and birth outcomes in Machinga district, Malawi. J Infect Dis (2013) 1.39
Drugs for preventing malaria in pregnant women in endemic areas: any drug regimen versus placebo or no treatment. Cochrane Database Syst Rev (2014) 1.38
Plasmodium falciparum parasites expressing pregnancy-specific variant surface antigens adhere strongly to the choriocarcinoma cell line BeWo. Infect Immun (2006) 1.37
Clindamycin as an antimalarial drug: review of clinical trials. Antimicrob Agents Chemother (2002) 1.36
Real-time quantitative PCR for determining the burden of Plasmodium falciparum parasites during pregnancy and infancy. J Clin Microbiol (2005) 1.36
A community effectiveness trial of strategies promoting intermittent preventive treatment with sulphadoxine-pyrimethamine in pregnant women in rural Burkina Faso. Malar J (2008) 1.35
Intermittent preventive treatment for the prevention of malaria during pregnancy in high transmission areas. Malar J (2007) 1.34
Systematic review and meta-analysis: rapid diagnostic tests versus placental histology, microscopy and PCR for malaria in pregnant women. Malar J (2011) 1.32
Impact of placental Plasmodium falciparum malaria on pregnancy and perinatal outcome in sub-Saharan Africa: I: introduction to placental malaria. Yale J Biol Med (2007) 1.32
Transcribed var genes associated with placental malaria in Malawian women. Infect Immun (2006) 1.32
Safety of artemether-lumefantrine in pregnant women with malaria: results of a prospective cohort study in Zambia. Malar J (2010) 1.31
Safety and efficacy of co-trimoxazole for treatment and prevention of Plasmodium falciparum malaria: a systematic review. PLoS One (2013) 1.29
Preventing malaria in pregnancy through community-directed interventions: evidence from Akwa Ibom State, Nigeria. Malar J (2011) 1.27
Malaria in pregnancy: the difficulties in measuring birthweight. BJOG (2011) 1.26
Impact of malaria during pregnancy on pregnancy outcomes in a Ugandan prospective cohort with intensive malaria screening and prompt treatment. Malar J (2013) 1.26
Pregnancy outcome and placenta pathology in Plasmodium berghei ANKA infected mice reproduce the pathogenesis of severe malaria in pregnant women. PLoS One (2008) 1.24
The role of Plasmodium falciparum var genes in malaria in pregnancy. Mol Microbiol (2004) 1.24
Micro-epidemiology of Plasmodium falciparum malaria: Is there any difference in transmission risk between neighbouring villages? Malar J (2007) 1.24
Diagnosis of Plasmodium falciparum malaria in pregnancy in sub-Saharan Africa: the challenges and public health implications. Parasitol Res (2007) 1.23
Perinatal mortality in rural Burkina Faso: a prospective community-based cohort study. BMC Pregnancy Childbirth (2010) 1.22
Adaptive evolution and fixation of drug-resistant Plasmodium falciparum genotypes in pregnancy-associated malaria: 9-year results from the QuEERPAM study. Infect Genet Evol (2011) 1.21
Prevalence and risk of Plasmodium falciparum and P. vivax malaria among pregnant women living in the hypoendemic communities of the Peruvian Amazon. Am J Trop Med Hyg (2007) 1.21
Prevention of malaria during pregnancy: assessing the effect of the distribution of IPTp through the national policy in Benin. Am J Trop Med Hyg (2011) 1.21
The A581G Mutation in the Gene Encoding Plasmodium falciparum Dihydropteroate Synthetase Reduces the Effectiveness of Sulfadoxine-Pyrimethamine Preventive Therapy in Malawian Pregnant Women. J Infect Dis (2015) 1.20
Nonimmune immunoglobulin binding and multiple adhesion characterize Plasmodium falciparum-infected erythrocytes of placental origin. Proc Natl Acad Sci U S A (2006) 1.18
Concern Interactions between natural killer cells, cortisol and prolactin in malaria during pregnancy. Clin Med Res (2006) 1.17
Prevalence of anemia in women with asymptomatic malaria parasitemia at first antenatal care visit at the University of Calabar Teaching Hospital, Calabar, Nigeria. Int J Womens Health (2010) 1.15
ABO blood group system and placental malaria in an area of unstable malaria transmission in eastern Sudan. Malar J (2007) 1.14
Markers of sulfadoxine-pyrimethamine-resistant Plasmodium falciparum in placenta and circulation of pregnant women. Antimicrob Agents Chemother (2006) 1.14
Implementing Intermittent Preventive Treatment for Malaria in Pregnancy: Review of Prospects, Achievements, Challenges and Agenda for Research. Open Trop Med J (2008) 1.14
Diagnostic comparison of malaria infection in peripheral blood, placental blood and placental biopsies in Cameroonian parturient women. Malar J (2009) 1.14
Human immunodeficiency virus co-infection increases placental parasite density and transplacental malaria transmission in Western Kenya. Am J Trop Med Hyg (2009) 1.12
Timing of malaria infection during pregnancy has characteristic maternal, infant and placental outcomes. PLoS One (2013) 1.12
Using an improved phagocytosis assay to evaluate the effect of HIV on specific antibodies to pregnancy-associated malaria. PLoS One (2010) 1.12
Cross-reactive surface epitopes on chondroitin sulfate A-adherent Plasmodium falciparum-infected erythrocytes are associated with transcription of var2csa. Infect Immun (2005) 1.11
Maternal morbidity: neglected dimension of safe motherhood in the developing world. Glob Public Health (2012) 1.11
Placental malaria among HIV-infected and uninfected women receiving anti-folates in a high transmission area of Uganda. Malar J (2009) 1.11
Submicroscopic Plasmodium falciparum malaria and low birth weight in an area of unstable malaria transmission in Central Sudan. Malar J (2013) 1.09
Malaria and anemia prevention in pregnant women of rural Burkina Faso. BMC Pregnancy Childbirth (2004) 1.09
Antenatal care visit attendance, intermittent preventive treatment during pregnancy (IPTp) and malaria parasitaemia at delivery. Malar J (2014) 1.09
Possession and usage of insecticidal bed nets among the people of Uganda: is BRAC Uganda Health Programme pursuing a pro-poor path? PLoS One (2010) 1.08
Immunogenicity of Duffy binding-like domains that bind chondroitin sulfate A and protection against pregnancy-associated malaria. Infect Immun (2006) 1.08
Pregnancy-associated malaria and the prospects for syndrome-specific antimalaria vaccines. J Exp Med (2004) 1.08
Submicroscopic malaria infection during pregnancy and the impact of intermittent preventive treatment. Malar J (2014) 1.07
Therapy of falciparum malaria in sub-saharan Africa: from molecule to policy. Clin Microbiol Rev (2004) 1.06
The effect of monthly sulfadoxine-pyrimethamine, alone or with azithromycin, on PCR-diagnosed malaria at delivery: a randomized controlled trial. PLoS One (2012) 1.06
Longitudinal studies of Plasmodium falciparum malaria in pregnant women living in a rural Cameroonian village with high perennial transmission. Am J Trop Med Hyg (2010) 1.06
Pregnancy exposure registries for assessing antimalarial drug safety in pregnancy in malaria-endemic countries. PLoS Med (2008) 1.06
Determinants of intermittent preventive treatment of malaria during pregnancy (IPTp) utilization in a rural town in Western Nigeria. Reprod Health (2012) 1.06
Fluorescence microscope (Cyscope) for malaria diagnosis in pregnant women in Medani Hospital, Sudan. Diagn Pathol (2011) 1.05
Prevalence and risk factors associated with malaria infection among pregnant women in a semi-urban community of north-western Nigeria. Infect Dis Poverty (2015) 1.05
Pregnancy-associated malaria in a rural community of ghana. Ghana Med J (2009) 1.04
First malaria infections in a cohort of infants in Benin: biological, environmental and genetic determinants. Description of the study site, population methods and preliminary results. BMJ Open (2012) 1.04
Prevention of malaria in pregnancy with intermittent preventive treatment and insecticide treated nets in Mali: a quantitative health systems effectiveness analysis. PLoS One (2013) 1.03
The Malaria in Pregnancy Library: a bibliometric review. Malar J (2012) 1.02
Diagnosing malaria in pregnancy: an update. Expert Rev Anti Infect Ther (2012) 1.01
Elevated levels of soluble TNF receptors 1 and 2 correlate with Plasmodium falciparum parasitemia in pregnant women: potential markers for malaria-associated inflammation. J Immunol (2010) 1.01
Malaria risk factors in women on intermittent preventive treatment at delivery and their effects on pregnancy outcome in Sanaga-Maritime, Cameroon. PLoS One (2013) 1.00
Concomitant efavirenz reduces pharmacokinetic exposure to the antimalarial drug artemether-lumefantrine in healthy volunteers. J Acquir Immune Defic Syndr (2012) 0.99
Placental histopathological changes associated with Plasmodium vivax infection during pregnancy. PLoS Negl Trop Dis (2013) 0.99
Malaria at parturition in Nigeria: current status and delivery outcome. Infect Dis Obstet Gynecol (2009) 0.98
Severity of maternal HIV-1 disease is associated with adverse birth outcomes in Malawian women: a cohort study. J Acquir Immune Defic Syndr (2013) 0.98
Parasite clearance following treatment with sulphadoxine-pyrimethamine for intermittent preventive treatment in Burkina-Faso and Mali: 42-day in vivo follow-up study. Malar J (2014) 0.98
Congenital Plasmodium falciparum malaria in sub-Saharan Africa: a rarity or frequent occurrence? Parasitol Res (2007) 0.98
Randomised trial of efficacy of SPf66 vaccine against Plasmodium falciparum malaria in children in southern Tanzania. Lancet (1994) 5.06
Intermittent treatment for malaria and anaemia control at time of routine vaccinations in Tanzanian infants: a randomised, placebo-controlled trial. Lancet (2001) 4.86
African children with malaria in an area of intense Plasmodium falciparum transmission: features on admission to the hospital and risk factors for death. Am J Trop Med Hyg (1999) 3.87
Efficacy of sulfadoxine-pyrimethamine for prevention of placental malaria in an area of Kenya with a high prevalence of malaria and human immunodeficiency virus infection. Am J Trop Med Hyg (1998) 3.74
Evaluation of an algorithm for integrated management of childhood illness in an area of Kenya with high malaria transmission. Bull World Health Organ (1997) 3.20
Placental pathology in malaria: a histological, immunohistochemical, and quantitative study. Hum Pathol (2000) 2.84
Effectiveness of intermittent preventive treatment with sulphadoxine-pyrimethamine for control of malaria in pregnancy in western Kenya: a hospital-based study. Trop Med Int Health (2004) 2.33
A longitudinal investigation of IgG and IgM antibody responses to the merozoite surface protein-1 19-kiloDalton domain of Plasmodium falciparum in pregnant women and infants: associations with febrile illness, parasitemia, and anemia. Am J Trop Med Hyg (1998) 2.33
Monitoring trends in under-5 mortality rates through national birth history surveys. Int J Epidemiol (2004) 2.21
Transmission of epidemic Vibrio cholerae O1 in rural western Kenya associated with drinking water from Lake Victoria: an environmental reservoir for cholera? Am J Trop Med Hyg (1999) 2.19
Maintenance and sustained use of insecticide-treated bednets and curtains three years after a controlled trial in western Kenya. Trop Med Int Health (1999) 2.05
Massive chronic intervillositis of the placenta associated with malaria infection. Am J Surg Pathol (1998) 2.05
Polymorphism in the gene encoding the apical membrane antigen-1 (AMA-1) of Plasmodium falciparum. X. Asembo Bay Cohort Project. Mol Biochem Parasitol (2001) 1.96
Glycosylphosphatidylinositol anchors of Plasmodium falciparum: molecular characterization and naturally elicited antibody response that may provide immunity to malaria pathogenesis. J Exp Med (2000) 1.87
Plasmodium falciparum malaria in the first year of life in an area of intense and perennial transmission. Trop Med Int Health (1996) 1.87
Placental malaria is associated with cell-mediated inflammatory responses with selective absence of natural killer cells. J Infect Dis (2001) 1.84
Studies on schistosomiasis in western Kenya: I. Evidence for immune-facilitated excretion of schistosome eggs from patients with Schistosoma mansoni and human immunodeficiency virus coinfections. Am J Trop Med Hyg (1997) 1.83
Identification of T and B cell epitopes recognized by humans in the C-terminal 42-kDa domain of the Plasmodium falciparum merozoite surface protein (MSP)-1. J Immunol (1995) 1.79
Natural immune response to the C-terminal 19-kilodalton domain of Plasmodium falciparum merozoite surface protein 1. Infect Immun (1996) 1.78
Plasmodium falciparum genotypes, low complexity of infection, and resistance to subsequent malaria in participants in the Asembo Bay Cohort Project. Infect Immun (2001) 1.66
Health insurance coverage among persons with AIDS: results from a multistate surveillance project. Am J Public Health (1994) 1.63
Mosquito-transmitted malaria in New York City, 1993. Lancet (1995) 1.63
Differential effect and interaction of monocytes, hyperimmune sera, and immunoglobulin G on the growth of asexual stage Plasmodium falciparum parasites. Am J Trop Med Hyg (1999) 1.62
A geographic information system applied to a malaria field study in western Kenya. Am J Trop Med Hyg (1998) 1.53
Risk factors for HIV infection among asymptomatic pregnant women attending an antenatal clinic in western Kenya. Int J STD AIDS (2000) 1.46
Analysis of repeated hemoglobin measures in full-term, normal birth weight Kenyan children between birth and four years of age. III. The Asemobo Bay Cohort Project. Am J Trop Med Hyg (1999) 1.41
The association between atopy and asthma in a semirural area of Tanzania (East Africa). Allergy (2000) 1.41
Predicted and observed alleles of Plasmodium falciparum merozoite surface protein-1 (MSP-1), a potential malaria vaccine antigen. Mol Biochem Parasitol (1998) 1.40
Longitudinal study of natural immune responses to the Plasmodium falciparum apical membrane antigen (AMA-1) in a holoendemic region of malaria in western Kenya: Asembo Bay Cohort Project VIII. Am J Trop Med Hyg (2001) 1.35
Immunity to placental malaria. I. Elevated production of interferon-gamma by placental blood mononuclear cells is associated with protection in an area with high transmission of malaria. J Infect Dis (1999) 1.32
Effect of Plasmodium falciparum parasitemia density on hemoglobin concentrations among full-term, normal birth weight children in western Kenya, IV. The Asembo Bay Cohort Project. Am J Trop Med Hyg (2000) 1.27
The incidence of clinical malaria detected by active case detection in children in Ifakara, southern Tanzania. Trans R Soc Trop Med Hyg (2005) 1.27
Identification of T-cell determinants in natural immune responses to the Plasmodium falciparum apical membrane antigen (AMA-1) in an adult population exposed to malaria. Infect Immun (1996) 1.26
Malaria, intestinal parasites, and schistosomiasis among Barawan Somali refugees resettling to the United States: a strategy to reduce morbidity and decrease the risk of imported infections. Am J Trop Med Hyg (2000) 1.22
Inter-observer variation in the assessment of clinical signs in sick Tanzanian children. Trans R Soc Trop Med Hyg (2002) 1.22
Fcgamma receptor IIa (CD32) polymorphism is associated with protection of infants against high-density Plasmodium falciparum infection. VII. Asembo Bay Cohort Project. J Infect Dis (2001) 1.21
Genetic conservation of the Plasmodium falciparum apical membrane antigen-1 (AMA-1). Mol Biochem Parasitol (1997) 1.20
Studies on schistosomiasis in western Kenya: II. Efficacy of praziquantel for treatment of schistosomiasis in persons coinfected with human immunodeficiency virus-1. Am J Trop Med Hyg (1998) 1.20
Isolation and enzymic properties of levansucrase secreted by Acetobacter diazotrophicus SRT4, a bacterium associated with sugar cane. Biochem J (1995) 1.15
Transmission of Plasmodium vivax malaria in San Diego County, California, 1986. Am J Trop Med Hyg (1990) 1.13
Adaptations of the Saker-Solomons test: simple, reliable colorimetric field assays for chloroquine and its metabolites in urine. Bull World Health Organ (1989) 1.11
Bubonic leishmaniasis: a common manifestation of Leishmania (Viannia) braziliensis infection in Ceara, Brazil. Am J Trop Med Hyg (1995) 1.10
Cytokine responses to Plasmodium falciparum liver-stage antigen 1 vary in rainy and dry seasons in highland Kenya. Infect Immun (2000) 1.10
Antibody responses to repetitive epitopes of the circumsporozoite protein, liver stage antigen-1, and merozoite surface protein-2 in infants residing in a Plasmodium falciparum-hyperendemic area of western Kenya. XIII. Asembo Bay Cohort Project. Am J Trop Med Hyg (2002) 1.09
All-cause mortality among young children in western Kenya. VI: the Asembo Bay Cohort Project. Am J Trop Med Hyg (2001) 1.08
Cost-effectiveness of sulfadoxine-pyrimethamine for the prevention of malaria-associated low birth weight. Am J Trop Med Hyg (2001) 1.08
Rolling back malaria in pregnancy. N Engl J Med (2000) 1.08
Effect of iron supplementation and malaria prophylaxis in infants on Plasmodium falciparum genotypes and multiplicity of infection. Trans R Soc Trop Med Hyg (1999) 1.03
Can malaria chemoprophylaxis be restricted to first pregnancies? Trans R Soc Trop Med Hyg (1995) 1.02
Immunity to placental malaria. II. Placental antigen-specific cytokine responses are impaired in human immunodeficiency virus-infected women. J Infect Dis (2000) 1.00
Probable locally acquired mosquito-transmitted malaria in Georgia, 1999. Clin Infect Dis (2001) 0.96
Malaria surveillance--United States, 1998. MMWR CDC Surveill Summ (2001) 0.95
Transmission of Staphylococcus aureus between mothers and infants in an African setting. Clin Microbiol Infect (2013) 0.95
Cytotoxic T cell reactivity and HLA-B35 binding of the variant Plasmodium falciparum circumsporozoite protein CD8+ CTL epitope in naturally exposed Kenyan adults. Eur J Immunol (1997) 0.93
Recognition of pallor associated with severe anaemia by primary caregivers in western Kenya. Trop Med Int Health (2002) 0.91
Does infection with Human Immunodeficiency Virus affect the antibody responses to Plasmodium falciparum antigenic determinants in asymptomatic pregnant women? J Infect (2003) 0.89
Mother-to-child transmission of HIV-1: association with malaria prevention, anaemia and placental malaria. HIV Med (2008) 0.89
Progression of stunting and its predictors among school-aged children in western Kenya. Eur J Clin Nutr (2005) 0.89
Sexuality in the climacteric years. Maturitas (2002) 0.89
Suppressed peripheral and placental blood lymphoproliferative responses in first pregnancies: relevance to malaria. Am J Trop Med Hyg (1993) 0.89
The distribution of birth weights in Gambian women who received malaria chemoprophylaxis during their first pregnancy and in control women. Trans R Soc Trop Med Hyg (1994) 0.85
Field-adapted method for high-performance thin-layer chromatographic detection and estimation of chloroquine and desethylchloroquine in urine. J Chromatogr (1987) 0.84
Human immunodeficiency virus seropositivity and malaria as risk factors for third-trimester anemia in asymptomatic pregnant women in western Kenya. Am J Trop Med Hyg (2001) 0.84
Field evaluation of a polymerase chain reaction-based nonisotopic liquid hybridization assay for malaria diagnosis. J Infect Dis (1996) 0.84
Evaluation of the SPf66 vaccine for malaria control when delivered through the EPI scheme in Tanzania. Trop Med Int Health (1999) 0.83
Malaria surveillance--United States, 1993. MMWR CDC Surveill Summ (1997) 0.83
Malaria surveillance -- United States, 1994. MMWR CDC Surveill Summ (1997) 0.83
Diurnal variation in body temperature of Gambian children. Trans R Soc Trop Med Hyg (1995) 0.83
Duration of protection and age-dependence of the effects of the SPf66 malaria vaccine in African children exposed to intense transmission of Plasmodium falciparum. J Infect Dis (1996) 0.82
Sensitivity of Plasmodium falciparum to chloroquine and sulfadoxine/pyrimethamine in Nigerian children. Bull World Health Organ (1990) 0.82
A trial of the synthetic malaria vaccine SPf66 in Tanzania: rationale and design. Vaccine (1994) 0.81
Immunologic memory in the placenta: a lymphocyte recirculation hypothesis. Med Hypotheses (2000) 0.81
Randomised trial of SPf66 vaccine against Plasmodium falciparum malaria in children in southern Tanzania. Med Trop (Mars) (1995) 0.81
Comparative flow cytometric analysis of term placental intervillous and peripheral blood from immediate postpartum women in Western kenya. Placenta (2003) 0.81
Humoral immune responses during a malaria vaccine trial in Tanzanian infants. Parasite Immunol (2000) 0.80
Vitamin A and iron supplementation in pregnancy. Lancet (1994) 0.80
Biochemical similarities between hypothyroidism and riboflavin deficiency. Endocrinology (1968) 0.80
Neonatal and maternal platelets: activation at time of birth. Am J Hematol (1988) 0.80
Influenza immunization for HIV-infected persons in Los Angeles. Vaccine (1995) 0.79
Poor response to primaquine in two cases of Plasmodium vivax malaria from Guatemala. Trop Geogr Med (1994) 0.78
International travel and the child younger than two years: I. Recommendations for immunization. Pediatr Infect Dis J (1989) 0.78
Dihydrotestosterone, stanozolol, androstenedione and dehydroepiandrosterone sulphate inhibit leptin secretion in female but not in male samples of omental adipose tissue in vitro: lack of effect of testosterone. J Endocrinol (1999) 0.77
The right not to know HIV-test results. Lancet (1995) 0.75
Postpartum coma. Lancet (1998) 0.75
[Determination of oxygen uptake during bycicle exercise. Comparative study between Douglas bag method and an automatic open system method (author's transl)]. Biomed Tech (Berl) (1978) 0.75
Changes in sex behaviour after menopause: effects of tibolone. Maturitas (1995) 0.75
The central nervous system and HRT. Int J Fertil Womens Med (2000) 0.75
A comparative study of the efficacies of chloroquine and a pyrimethamine-dapsone combination in clearing Plasmodium falciparum parasitaemia in school children in Tanzania. Trop Med Int Health (1996) 0.75
Theoretical considerations in estimating the growth hormone axis in adults. Growth Horm IGF Res (1998) 0.75
Diagnosis of the child with fever in the emergency department (continuing education credit). J Emerg Nurs (1989) 0.75
Effects of oestradiol administration via different routes on the lipid profile in women with bilateral oophorectomy. Maturitas (1994) 0.75
Sushi in pregnancy, parasitic diseases - obstetrician survey. Zoonoses Public Health (2011) 0.75
AIDS cases with wasting syndrome who meet the CDC surveillance criteria. J Acquir Immune Defic Syndr (1993) 0.75
Safety in infants of SPf66, a synthetic malaria vaccine, delivered alongside the EPI. Trop Med Int Health (1999) 0.75